Emergent Biosolutions, Inc. (EBS) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "EBS"
      ],
      "issuer_cik": "0001367644",
      "owner_cik": "0001583098",
      "accession_number": "0001583098-26-000008",
      "form_type": "4",
      "filing_date": "2026-10-07",
      "period_of_report": "2026-10-07",
      "issuer_name": "Emergent BioSolutions Inc.",
      "issuer_trading_symbol": "EBS",
      "owner_name": "DeGolyer Donald W",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-07",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 17800,
      "transaction_price_per_share": 7.09,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 111921,
      "transaction_value": 126202,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to\nthe vesting of RSUs on October 2, 2026."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6.88 to $7.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."
        }
      ]
    },
    {
      "tickers": [
        "EBS"
      ],
      "issuer_cik": "0001367644",
      "owner_cik": "0001961994",
      "accession_number": "0001961994-26-000029",
      "form_type": "4",
      "filing_date": "2026-10-05",
      "period_of_report": "2026-10-01",
      "issuer_name": "Emergent BioSolutions Inc.",
      "issuer_trading_symbol": "EBS",
      "owner_name": "Williams Paul Anthony",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "SVP, Products Business",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-01",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 3000,
      "transaction_price_per_share": 6.53,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 156098,
      "transaction_value": 19590,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6.52 to $6.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.